Invesco’s Century Therapeutics IPSC Stock Holding History

Invesco’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$934K	Buy	381,419 +319,310	+514%	+$729K	﹤0.01%	2955
2026 Q1	$140K	Buy	+62,109	New	+$131K	﹤0.01%	3579

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Invesco's IPSC Position: Q2 2026 in Review

Invesco increased its Century Therapeutics (IPSC) stake by 514% in Q2 2026, buying an estimated $729K and bringing the position to 381,419 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Invesco first reported a position in IPSC in Q1 2026 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Invesco held 381,419 shares of Century Therapeutics worth $934K as of Q2 2026.
Invesco bought 319,310 Century Therapeutics shares in Q2 2026, an estimated $729K.
Century Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2955 holding.
Invesco first reported a position in Century Therapeutics in Q1 2026 and has held it in 2 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.